Table 3.
Description of symptoms in the control group.
| Symptom | Data>* |
|---|---|
| Nephrological symptoms | |
| Follow-up assessmenta | 3/15 (20%) |
| Enuresis nocturna | 1/15 (6.6%) |
| Generalised symptoms | |
| Fatigue | 1/15 (6.6%) |
| Gastrointestinal symptoms | |
| Follow-up assessmenta | 4/15 (26.6%) |
| Abdominal pain | 3/30 (20%) |
| Diarrhoea | 1/30 (6.6%) |
| Hematemesis | 1/30 (6.6%) |
| Endocrine symptoms | |
| Follow-up assessmenta | 1/30 (6.6%) |
| Psychological/psychiatric symptoms | |
| Lack of weight gain | 1/30 (6.6%) |
*
Data are presented as n/N (%).
a
Asymptomatic follow-up assessment in the context of the pre-existing conditions.